Sarah Gerlo Selected Research

mitogen and stress-activated protein kinase 1

4/2009	Glucocorticoids and mitogen- and stress-activated protein kinase 1 inhibitors: possible partners in the combat against inflammation.
4/2007	A critical role for p53 in the control of NF-kappaB-dependent gene expression in TLR4-stimulated dendritic cells exposed to Genistein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sarah Gerlo Research Topics

Disease

6	Neoplasms (Cancer) 11/2021 - 04/2007
6	Inflammation (Inflammations) 07/2014 - 10/2006
2	Infections 02/2022 - 01/2020
2	COVID-19 01/2022 - 11/2021
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2016 - 07/2014
2	Multiple Myeloma 01/2014 - 08/2008
2	Asthma (Bronchial Asthma) 04/2012 - 12/2010
1	HIV Infections (HIV Infection) 01/2022
1	Human Influenza (Influenza) 01/2020
1	Metabolic Diseases (Metabolic Disease) 09/2015
1	Astrocytoma (Pilocytic Astrocytoma) 01/2014
1	Fibrosarcoma 01/2014
1	Necrosis 01/2014
1	Respiratory Hypersensitivity 04/2012
1	Metaplasia 04/2012
1	Immune System Diseases (Immune Disorders) 01/2012
1	Alzheimer Disease (Alzheimer's Disease) 06/2011
1	Multiple Sclerosis 06/2011
1	Nervous System Diseases (Neurological Disorders) 06/2011
1	Parkinson Disease (Parkinson's Disease) 06/2011
1	Glioma (Gliomas) 04/2011
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2010
1	Gliosis 07/2010
1	Neoplasm Metastasis (Metastasis) 05/2010

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 11/2021 - 12/2010
4	Interleukin-6 (Interleukin 6)IBA 06/2011 - 04/2007
3	GlucocorticoidsIBA 01/2014 - 04/2009
2	AntibodiesIBA 02/2022 - 01/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2021 - 04/2007
2	Immune Checkpoint InhibitorsIBA 01/2018 - 01/2018
2	Interferon Type IIBA 01/2018 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2014 - 05/2010
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2014 - 04/2012
2	mitogen and stress-activated protein kinase 1IBA 04/2009 - 04/2007
2	NF-kappa B (NF-kB)IBA 04/2007 - 10/2006
1	Biomarkers (Surrogate Marker)IBA 02/2022
1	Immunoglobulin G (IgG)IBA 02/2022
1	VaccinesIBA 01/2022
1	LipidsIBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	NucleotidesIBA 11/2021
1	Interleukin-1 (Interleukin 1)IBA 11/2021
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2020
1	InflammasomesIBA 01/2020
1	atezolizumabIBA 01/2018
1	Tumor Biomarkers (Tumor Markers)IBA 01/2018
1	DipeptidesIBA 09/2015
1	CarnosineIBA 09/2015
1	Insulin (Novolin)FDA Link 07/2014
1	InterferonsIBA 07/2014
1	ClenbuterolIBA 01/2014
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2014
1	VenomsIBA 01/2014
1	Hormones (Hormone)IBA 01/2014
1	Messenger RNA (mRNA)IBA 01/2014
1	MicroRNAs (MicroRNA)IBA 01/2014
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2012
1	CollagenIBA 04/2012
1	2- (4- acetoxyphenyl)- 2- chloro- N- methylethylamineIBA 04/2012
1	LigandsIBA 01/2012
1	Phosphodiesterase InhibitorsIBA 12/2010
1	Nerve Growth Factors (Neurotrophins)IBA 07/2010
1	GlycogenIBA 07/2010
1	CaspasesIBA 05/2010
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2010
1	Transcription Factors (Transcription Factor)IBA 05/2010
1	Pharmaceutical PreparationsIBA 05/2010
1	QuercetinIBA 05/2010
1	withaferin AIBA 05/2010
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2010
1	PolyphenolsIBA 05/2010
1	GenisteinIBA 04/2007

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2014
3	Immunotherapy 11/2021 - 01/2018
2	Drug Therapy (Chemotherapy) 01/2018 - 01/2018